American Healthcare REIT, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that American Healthcare REIT, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.26B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.87B | Feb 27, 2026 |
| FY2019 | Dec 31, 2019 | $33.44M | Mar 19, 2020 |
| FY2019 | Sep 30, 2019 | $31.12M | Mar 19, 2020 |
| FY2019 | Jun 30, 2019 | $30.37M | Mar 19, 2020 |
| FY2019 | Mar 31, 2019 | $25.84M | Mar 19, 2020 |
| FY2019 | Dec 31, 2018 | $25.32M | Mar 19, 2020 |
| FY2019 | Sep 30, 2018 | $22.28M | Mar 19, 2020 |
| FY2019 | Jun 30, 2018 | $19.01M | Mar 19, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.88B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.67B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.41B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.12B | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.07B | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.10B | Mar 25, 2022 |
| FY2020 | Dec 31, 2018 | $36.86M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $5.56M | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Mar 18, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $33.33M | Mar 8, 2018 |
| FY2017 | Dec 31, 2016 | $3.16M | Mar 8, 2018 |
| FY2017 | Dec 31, 2015 | $0 | Mar 8, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $69.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($37.81M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($71.47M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($81.30M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($47.79M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $2.16M | Mar 17, 2023 |
| FY2019 | Dec 31, 2019 | $1.32M | Mar 19, 2020 |
| FY2019 | Sep 30, 2019 | ($1.90M) | Mar 19, 2020 |
| FY2019 | Jun 30, 2019 | ($5.86M) | Mar 19, 2020 |
| FY2019 | Mar 31, 2019 | ($12.34M) | Mar 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $415.16M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $363.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $306.83M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $301.97M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $213.34M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $218.28M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $221.40M | Mar 25, 2022 |
| FY2016 | Dec 31, 2016 | ($2.16M) | Mar 1, 2017 |
| FY2016 | Sep 30, 2016 | ($2.04M) | Mar 1, 2017 |
| FY2016 | Jun 30, 2016 | ($613.0K) | Mar 1, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $294.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $176.09M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $98.54M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $147.77M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $17.91M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $219.16M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $117.45M | Mar 25, 2022 |
| FY2020 | Dec 31, 2018 | $15.42M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $12.40M | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | ($3.62M) | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.43B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.49B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.58B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.79B | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $4.58B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.23B | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.07B | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $896.37M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $480.15M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $142.76M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.18B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.12B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.14B | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.75B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.16B | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $476.79M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $337.33M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $125.93M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $50.50M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.32B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.26B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.27B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.40B | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.58B | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $866.11M | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | $590.08M | Mar 26, 2021 |
| FY2016 | Dec 31, 2016 | $92.26M | Mar 1, 2017 |
| FY2016 | Dec 31, 2015 | $200.0K | Mar 1, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $234.94M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $234.94M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.33M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $231.61M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $209.90M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $75.31M | Mar 17, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.56B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($1.46B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($1.28B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($1.14B) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($951.30M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($864.27M) | Mar 25, 2022 |
| FY2020 | Dec 31, 2019 | ($130.61M) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($64.78M) | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | ($23.48M) | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | ($7.35M) | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.84M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $76.70M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $43.45M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $65.05M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $81.60M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $113.21M | Mar 22, 2024 |
| FY2022 | Dec 31, 2019 | $53.15M | Mar 17, 2023 |
| FY2021 | Dec 31, 2018 | $35.13M | Mar 25, 2022 |
| FY2020 | Dec 31, 2017 | $7.09M | Mar 26, 2021 |
| FY2019 | Dec 31, 2016 | $2.24M | Mar 19, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 25, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 25, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | 179.66M | Mar 25, 2022 |
| FY2015 | Dec 31, 2015 | 20,833 | Mar 7, 2016 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $163.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $120.90M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $76.28M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $51.12M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $22.79M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $27.00M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $62.61M | Mar 25, 2022 |
| FY2020 | Dec 31, 2018 | $13.99M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $6.40M | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | $549.0K | Mar 18, 2019 |